BioGaia AB (publ) 

SEK116.5
6
+SEK0.7+0.6% Friday 15:29

统计数据

当日最高
117.5
当日最低
115
52周最高
136.6
52周最低
91.45
成交量
67,042
平均成交量
91,628
市值
12.16B
市盈率
30.2
股息收益率
1.63%
股息
1.9

即将到来

股息

1.63%股息收益率
10年增长
22.57%
5年增长
42.44%
3年增长
90.97%
1年增长
31.03%

收益

22Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
0.61
0.78
0.94
1.11
预期每股收益
0.81563104738
实际每股收益
N/A

人们还关注

此列表基于关注BIOG-B.ST的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.
Show more...
首席执行官
Mr. Peter Rothschild M.Sc. Econ., MBA
员工
220
国家
SE

上市公司